Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
All Dana-Farber/Boston Children's patients have access to the entire spectrum of expertise that is required to treat pediatric cancers and blood disorders. Pediatric patients of the Childhood Hematologic Malignancy Center and its specialized programs for leukemia, lymphoma, and histiocytosis are each assigned a multidisciplinary team that works closely together to create and carry out a treatment plan carefully tailored to the child’s specific needs.
Patient care teams include:
Meet our Childhood Hematologic Malignancy Center Team.
In addition, our teams also draw on the expertise and knowledge of a variety of subspecialists and support staff available to Dana-Farber/Boston Children's patients, including:
Dana-Farber/Boston Children’s offers a wide array of support services and programs for pediatric patients and their families during and after cancer treatment.
New Patient Appointments
Find answers to common questions about clinical trials for
childhood cancer, including whether or not a clinical trial may be the right
choice for your child. You can also email your questions to email@example.com